This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a subsidiary of parent company Cencora, Inc. The $1,748.61 contract is for the delivery of Fluticasone Prop HFA 220 MCG 12GM, a prescription pharmaceutical product, to support military medical treatment programs. The order has a completion date of March 5, 2024 and was awarded on March 4, 2024. No set-aside was used for this award. AmerisourceBergen Drug Corporation serves as a prime contractor for DLA, providing a wide range of pharmaceutical products and medical supplies through indefinite delivery contracts with a potential value of up to $999,999,999.00 through December 2025. These contracts enable the company to deliver medications and healthcare materials to military treatment facilities worldwide.
Generated 6/3/24, 9:03 AM